chemotherapy: be given after mastectomy

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents treatment
Weight: 0.64
, regimen
Weight: 0.62
, modality
Weight: 0.61
, agent
Weight: 0.60
, prostate cancer
Weight: 0.59
Siblings gene therapy
Weight: 0.66
, breast cancer
Weight: 0.36
, dialysis
Weight: 0.36
, transplant
Weight: 0.34
, mastectomy
Weight: 0.34

Related properties

Property Similarity
be given after mastectomy 1.00
be given after surgery 0.84
be given before surgery 0.82
be vs lumpectomy 0.82
be used after surgery 0.81
is surgery 0.80
be done before surgery 0.80
be used before surgery 0.80
be used for breast cancer 0.78
be better than radiotherapy 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.03
Rule weight: 0.13
Evidence weight: 0.28
Similarity weight: 0.82
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.73
¬ Remarkable(mastectomy, be vs lumpectomy)
0.01
Rule weight: 0.13
Evidence weight: 0.09
Similarity weight: 0.80
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.93
¬ Remarkable(mastectomy, is surgery)

Remarkability from sibling implausibility

0.48
Rule weight: 0.60
Evidence weight: 0.99
Similarity weight: 0.80
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.93
Remarkable(mastectomy, is surgery) ⋁
Evidence: 0.20
¬ Plausible(mastectomy, is surgery)
0.40
Rule weight: 0.60
Evidence weight: 0.81
Similarity weight: 0.82
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.73
Remarkable(mastectomy, be vs lumpectomy) ⋁
Evidence: 0.93
¬ Plausible(mastectomy, be vs lumpectomy)

Salient implies Plausible

0.16
Rule weight: 0.28
Evidence weight: 0.59
Similarity weight: 1.00
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.56
¬ Salient(chemotherapy, be given after mastectomy)

Similarity expansion

0.70
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.84
Evidence: 0.98
Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.96
¬ Remarkable(chemotherapy, be given after surgery)
0.69
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.82
Evidence: 0.98
Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.84
¬ Remarkable(chemotherapy, be given before surgery)
0.68
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.81
Evidence: 0.98
Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be used after surgery)
0.67
Rule weight: 0.85
Evidence weight: 0.97
Similarity weight: 0.81
Evidence: 0.04
Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.03
¬ Typical(chemotherapy, be used after surgery)
0.67
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.84
Evidence: 0.04
Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.06
¬ Typical(chemotherapy, be given after surgery)
0.67
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.80
Evidence: 0.98
Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.79
¬ Remarkable(chemotherapy, be done before surgery)
0.67
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.80
Evidence: 0.98
Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.92
¬ Remarkable(chemotherapy, be used before surgery)
0.65
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.98
Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.77
¬ Remarkable(chemotherapy, be used for breast cancer)
0.64
Rule weight: 0.85
Evidence weight: 0.98
Similarity weight: 0.77
Evidence: 0.98
Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be better than radiotherapy)
0.62
Rule weight: 0.85
Evidence weight: 0.95
Similarity weight: 0.77
Evidence: 0.04
Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.05
¬ Typical(chemotherapy, be better than radiotherapy)
0.58
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.81
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.23
¬ Plausible(chemotherapy, be used after surgery)
0.57
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.84
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.27
¬ Plausible(chemotherapy, be given after surgery)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.80
Evidence: 0.04
Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.21
¬ Typical(chemotherapy, be used before surgery)
0.54
Rule weight: 0.85
Evidence weight: 0.76
Similarity weight: 0.84
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.55
¬ Salient(chemotherapy, be given after surgery)
0.53
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.81
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.53
¬ Salient(chemotherapy, be used after surgery)
0.52
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.77
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.27
¬ Plausible(chemotherapy, be better than radiotherapy)
0.49
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.77
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.57
¬ Salient(chemotherapy, be better than radiotherapy)
0.48
Rule weight: 0.85
Evidence weight: 0.71
Similarity weight: 0.80
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.65
¬ Salient(chemotherapy, be used before surgery)
0.48
Rule weight: 0.85
Evidence weight: 0.68
Similarity weight: 0.82
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.72
¬ Salient(chemotherapy, be given before surgery)
0.48
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.80
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.40
¬ Plausible(chemotherapy, be used before surgery)
0.43
Rule weight: 0.85
Evidence weight: 0.61
Similarity weight: 0.82
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.53
¬ Plausible(chemotherapy, be given before surgery)
0.42
Rule weight: 0.85
Evidence weight: 0.62
Similarity weight: 0.80
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.87
¬ Salient(chemotherapy, be done before surgery)
0.41
Rule weight: 0.85
Evidence weight: 0.58
Similarity weight: 0.82
Evidence: 0.04
Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.44
¬ Typical(chemotherapy, be given before surgery)
0.39
Rule weight: 0.85
Evidence weight: 0.59
Similarity weight: 0.78
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.92
¬ Salient(chemotherapy, be used for breast cancer)
0.31
Rule weight: 0.85
Evidence weight: 0.46
Similarity weight: 0.80
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.72
¬ Plausible(chemotherapy, be done before surgery)
0.26
Rule weight: 0.85
Evidence weight: 0.40
Similarity weight: 0.78
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.81
¬ Plausible(chemotherapy, be used for breast cancer)
0.23
Rule weight: 0.85
Evidence weight: 0.33
Similarity weight: 0.80
Evidence: 0.04
Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.70
¬ Typical(chemotherapy, be done before surgery)
0.16
Rule weight: 0.85
Evidence weight: 0.24
Similarity weight: 0.78
Evidence: 0.04
Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.79
¬ Typical(chemotherapy, be used for breast cancer)

Typical and Remarkable implies Salient

0.14
Rule weight: 0.14
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.56
Salient(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.04
¬ Typical(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy)

Typical implies Plausible

0.46
Rule weight: 0.48
Evidence weight: 0.97
Similarity weight: 1.00
Evidence: 0.26
Plausible(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.04
¬ Typical(chemotherapy, be given after mastectomy)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.96
Similarity weight: 0.80
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.04
¬ Typical(mastectomy, is surgery)
0.06
Rule weight: 0.14
Evidence weight: 0.53
Similarity weight: 0.82
Evidence: 0.98
¬ Remarkable(chemotherapy, be given after mastectomy) ⋁
Evidence: 0.48
¬ Typical(mastectomy, be vs lumpectomy)